CoChat

The 16,17-Double Bond Is Needed for Irreversible Inhibition of Human Cytochrome P45017α by Abiraterone (17-(3-Pyridyl)androsta-5,16-dien-3β-ol) and Related Steroidal Inhibitors

Jarman, Michael, Barrie, S. Elaine, Llera, Jose M. · 1998 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.

Abstract

Abiraterone (17-(3-pyridyl)androsta-5,16-dien-3beta-ol, 1) is a potent inhibitor (IC50 4 nM for hydroxylase) of human cytochrome P45017alpha. To assist in studies of the role of the 16,17-double bond in its mechanism of action, the novel 17alpha-(4-pyridyl)androst-5-en-3beta-ol (5) and 17beta-(3-pyridyl)-16,17alpha-epoxy-5alpha-androst-3beta-ol (6) were synthesized. 3beta-Acetoxyetienic acid was converted in three steps into 5 via photolysis of the thiohydroxamic ester 8. Oxidation of an appropriate 16,17-unsaturated precursor (21) with CrO3-pyridine afforded the acetate (23) of 6. Inhibition of the enzyme by 1, the similarly potent 5,6-reduced analogue 19 (IC50 5 nM), and the 4, 16-dien-3-one 26 (IC50 3 nM) and by the less potent (IC50 13 nM) 3,5, 16-triene 25 is slow to occur but is enhanced by preincubation of the inhibitor with the enzyme. Inhibition following preincubation with these compounds is not lessened by dialysis for 24 h, implying irreversible binding to the enzyme. In contrast under these conditions the still potent (IC50 27 nM) 17alpha-(4-pyridyl)androst-5-en-3beta-ol (5) showed partial reversal after 5 h of dialysis and complete reversal of inhibition after 24 h. This behavior was also shown by the less potent 16,17-reduced 3-pyridyl compounds 3 and 24. Further, in contrast to the compounds (1, 19, 25, 26) with the 16,17-double bond, the inhibition of the enzymic reaction was not enhanced by preincubation either with 5 or with the 17beta-pyridyl analogues 3, 4, and 24 which also lack this structural feature. The results show that the 16,17-double bond is necessary for irreversible binding of these pyridyl steroids to cytochrome P45017alpha. However oxidation to an epoxide is probably not involved since epoxide 6 was only a moderately potent inhibitor (IC50 260 nM).

Overview

Integrity signals

Registry

Crossref · 10.1021/jm981017j

Cites

16 of 16 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 16 references

Research works printed but not linked: 9

  1. Rowlands M. G., 1996, J. Med. Chem., 38, 4197
  2. Chan F. C. Y., 1996, J. Med. Chem., 39, 3323
  3. Burke D. F. Ph.D., 1994, University of London
  4. Sato T., 1995, J. Org. Chem., 60, 2629
  5. Garreg P., 1982, J. Chem Soc., Perkin Trans. 1, 681, 683
  6. Barton D. H. R., 1986, Tetrahedron Lett., 27, 1330
  7. Catagnino E., 1986, Tetrahedron Lett., 27, 6338
  8. Bo T., 1996, Synthesis, 324, 326
  9. Pearson A. J., 1985, J. Chem. Soc., Perkin Trans. 1, 267, 273

Cited by

Metadata

Authors
Jarman, M., Barrie, S. E., & Llera, J. M.
Affiliations
Institute of Cancer Research (GB)
Venue
Journal of Medicinal Chemistry
Published
1998-12-01
Volume
41
Issue
27
Pages
5375-5381
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2110171529
Cited by
151
References
16
Citations by year
2025: 2 · 2024: 6 · 2023: 5 · 2022: 5 · 2021: 9 · 2020: 6 · 2019: 8 · 2018: 5 · 2017: 5 · 2016: 15 · 2015: 9 · 2014: 7 · 2013: 16 · 2012: 11
FWCI
0.47
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Physical Sciences › Chemistry › Organic Chemistry › Steroid Chemistry and Biochemistry
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
Keywords
abiraterone, irreversible enzyme inhibition, structure-activity relationship, androgen production
MeSH terms
Androstanols, Androstenes, Androstenols, Enzyme Inhibitors, Humans, Kinetics, Male, Pyridines, Steroid 17-alpha-Hydroxylase, Structure-Activity Relationship, Testis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.